Assembly Biosciences, Inc. (ASMB)

Assembly Biosciences, Inc. (ASMB) is a healthcare company (biotechnology) based in the United States. The share price is $22.18, up 4.18% on the day, which values the company at $454.19M. Price as of 17 Nov 2026, 17:26 UTC, from Yahoo Finance.

Key facts

Share price
$22.18+4.18% today
Market value
$454.19M
P/E ratio
29.6×last 12 months
Funk Score
39/100
Against its own history
Below its usual priceusual price $28.75
200-week average
$18.4021% above
Sector
Healthcare

Figures as of . Prices from Yahoo Finance (may be delayed); statements from company filings with the SEC and Yahoo Finance. Estimates, not advice.

Assembly Biosciences, Inc. in more detail

ASMB trades at 29.6× its last twelve months' earnings, -8.8× next year's expected earnings, 6.8× sales. Measured against its own history, the price is 23% below what its usual multiples would imply ($28.75) — below its usual price. It sits 21% above its 200-week average of $18.40.

Over the last five fiscal years Assembly Biosciences, Inc. has compounded revenue -1.8% a year. Its Funk Score is 39 out of 100 (financial strength 5.6, profitability 2.5, growth 3.6, value 4.0, each out of 10).

In its favour: More cash than debt. Worth checking: Share count keeps rising.

2 of the superinvestors tracked here hold ASMB, including Peter Kolchinsky (0.2% of the portfolio), Andrew Spokes (0.2% of the portfolio).

Superinvestors holding ASMB

2 of the investors tracked here report a position in their latest 13F filing.

Assembly Biosciences, Inc. (ASMB): questions and answers

What is ASMB's P/E ratio?

Assembly Biosciences, Inc. trades at 29.6× its last twelve months' earnings and -8.8× next year's expected earnings.

What is Assembly Biosciences, Inc.'s market cap?

Assembly Biosciences, Inc. is valued at $454.19M at a share price of $22.18.

Is ASMB overvalued or undervalued?

Against its own history, ASMB is below its usual price: the price is 23% below the $28.75 implied by the median multiples it has traded at (price / sales, price / book). That compares the stock with its past; it does not say whether the business now deserves a higher or lower multiple.

Is ASMB above its 200-week moving average?

Yes. ASMB is 20.5% above its 200-week average of $18.40. Long-term investors watch that line because strong companies rarely trade below it for long.

How fast is Assembly Biosciences, Inc. growing?

Over the last five fiscal years Assembly Biosciences, Inc.'s revenue grew -1.8% a year.

Does ASMB pay a dividend?

Assembly Biosciences, Inc. does not currently pay a regular dividend.

Cite this page

Funkfolio, “Assembly Biosciences, Inc. (ASMB) stock: price, valuation and fundamentals”, data as of 17 November 2026. https://funkfolio.com/stock/ASMB

Underlying data: Yahoo Finance; company filings with the SEC.